Navigation Links
Poor Glycaemic Control In Hispanics With Diabetes Causes Severe Depression

A significant association exists between depression severity and poor Glycaemic control (PGC) in Hispanics with diabetes and less than one-third of the diabetics were found having received mental health treatment, // according to a study by researchers at Columbia University's Mailman School of Public Health and College of Physicians and Surgeons.

The study involved 200 Hispanics with diabetes. "We found a steady increase in the probability of PGC with advancing categories of depression severity," according to Raz Gross, MD, MPH assistant professor of Epidemiology and Psychiatry at Columbia University's Mailman School of Public Health and College of Physicians and Surgeons and principal author of the study.

"This held especially true among patients with moderate-severe depression, where likelihood for PGC was more than three-fold higher compared to patients without depression," said Dr. Gross.

However, there is no such association found in non-Hispanic diabetics.

Hispanics have high incident rates of diabetes and are more likely to have poor Glycaemic control. Diabetes ranks fifth among the leading causes of death in people of Hispanic origin.

Earlier studies have indicated that Hispanic diabetics are usually less likely to have regular sources of medical care for screening or preventive services. Many Hispanics cannot go to a specialist or receive appropriate treatment.

This study may be of clinical significance because, “our findings suggest that identification and adequate treatment of depression in this understudied, high-risk population of Hispanic primary care patients might have favourable effects on diabetic outcomes," said Dr. Gross.

Source: Journal of General Internal Medicine.
'"/>




Page: 1

Related medicine news :

1. Glycaemic Index as an index of diet and tool questioned
2. Australian Firm Develops Low Glycaemic Sugar to Prevent Diabetes
3. FDA Approves Birth Control Skin Patch
4. Control of inflammation
5. New Birth Control Pills increase the stroke risk
6. Control of anger disorder connected to Brain Dysfunction
7. WHO Declares Vietnam First Country to Control SARS
8. The Importance Of “ Good ”Control Of Diabetes During Pregnanc
9. Controlling Asthma during Pregnancy
10. Effective Control Of Blood Sugar Levels
11. Controlling Allergies Before They Start
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: